97. 潰瘍性大腸炎 Ulcerative colitis Clinical trials / Disease details
臨床試験数 : 2,630 / 薬物数 : 1,459 - (DrugBank : 265) / 標的遺伝子数 : 144 - 標的パスウェイ数 : 202
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT04360343 (ClinicalTrials.gov) | July 1, 2020 | 6/4/2020 | Compare the Pharmacokinetics, Pharmacodynamics and Safety/Tolerability of LC51-0255 Film-coated Tablet (SG85) With LC51-0255 Uncoated Tablet (SG82) in Healthy Subjects | A Randomized, Open-label, Single Dose, 2-period, 2-sequence, 2-treatment, Crossover Study to Compare the Pharmacokinetics, Pharmacodynamics and Safety/Tolerability of LC51-0255 Film-coated Tablet (SG85) With LC51-0255 Uncoated Tablet (SG82) in Healthy Subjects | Ulcerative Colitis | Drug: Film-coated tablet | LG Chem | NULL | Completed | 19 Years | 45 Years | All | 18 | Phase 1 | Korea, Republic of |
2 | NCT04096573 (ClinicalTrials.gov) | April 2020 | 18/9/2019 | Efficacy and Safety of LC51-0255 in Subjects With Ulcerative Colitis | A Phase 2, Multi Center, Randomized, Placebo Controlled Parallel Group Study to Evaluate the Clinical Efficacy and Safety of LC51 0255 in Subjects With Moderately to Severely Active Ulcerative Colitis | Ulcerative Colitis | Drug: LC51-0255;Drug: Placebo | LG Chem | NULL | Withdrawn | 18 Years | 80 Years | All | 0 | Phase 2 | NULL |